drugset / Trial / NCT00155714
Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary Hypertension
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The aim of this trial is to evaluate the efficacy of type-5 phosphodiesterase inhibitors (sildenafil) in primary and secondary pulmonary hypertension
Timeline
- Start
- 2002-11
- Primary completion
- —
- Completion
- 2005-05
Outcome
Outcome not reported
Stopped: “We can't obtained the test drug (Vadenafil) from Bayer. They decided not to carry out this trail in Taiwan. Therefore this trail has never been started.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sildenafil | Unknown | — | — |